CRNX•benzinga•
Stifel Initiates Coverage On Crinetics Pharmaceuticals with Buy Rating, Announces Price Target of $60
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 25, 2025 by benzinga